5-amino-1mq and cd38 inhibitor synergy nad+ Nicotinamide N-Methyltransferase in Cardiovascular Diseases: Metabolic Regulator Emerging Therapeutic Target Selective and membrane-permeable small molecule
Selective and membrane permeable small molecule inhibitors of nicotinamide N methyltransferase reverse high fat diet induced obesity in mice PMC A Potent and Specific CD38 Inhibitor Ameliorates Age Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline ScienceDirect Rapid Discovery of CD38 Inhibitor via DNA Encoded Natural Product Library Screening What Is MitoPrime? NAD+ MOTS c 5 Amino 1MQ Blend (2026) Peptide Mind Frontiers Nicotinamide N methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice Scientific Reports
Pay in 4 interest-free payments of $6.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4





